EGFR and lung adenocarcinoma: Serum carcinoembryonic antigen (CEA) has potential prognostic and monitoring significance in lung adenocarcinoma (LUAD) patients undergoing different treatments, such as epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) and chemotherapy.